18
Views
7
CrossRef citations to date
0
Altmetric
Original article

Serum levels of soluble intercellular adhesion molecule-1 (s-ICAM-1) and soluble endothelial leukocyte adhesion molecule-1(s-ELAM-1) in amyotrophic lateral sclerosis

, , , &
Pages 118-121 | Received 05 Apr 2004, Accepted 15 Dec 2004, Published online: 20 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Henrik Ryberg & Robert Bowser. (2008) Protein biomarkers for amyotrophic lateral sclerosis. Expert Review of Proteomics 5:2, pages 249-262.
Read now
Jaydeep M Bhatt & Paul H Gordon. (2007) Current clinical trials in amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 16:8, pages 1197-1207.
Read now

Articles from other publishers (5)

Yuko Kobayakawa, Koji Todaka, Yu Hashimoto, Senri Ko, Wataru Shiraishi, Junji Kishimoto, Jun-ichi Kira, Ryo Yamasaki & Noriko Isobe. (2022) A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 442, pages 120389.
Crossref
Alexandre Brodovitch, José Boucraut, Emilien Delmont, Amandine Parlanti, Aude-Marie Grapperon, Shahram Attarian & Annie Verschueren. (2021) Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS. Scientific Reports 11:1.
Crossref
Syed I. Khalid, Leonel Ampie, Ryan Kelly, Shafeeq S. Ladha & Christopher Dardis. (2017) Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials. Frontiers in Neurology 8.
Crossref
Yang Hu, Chang Cao, Xiao-Yan Qin, Yun Yu, Jing Yuan, Yu Zhao & Yong Cheng. (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Scientific Reports 7:1.
Crossref
B. J. TraynorL. BruijnR. ConwitF. BealG. O’NeillS. C. FaganM. E. Cudkowicz. (2006) Neuroprotective agents for clinical trials in ALS. Neurology 67:1, pages 20-27.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.